The importance of postprandial glucose to treatments and outcomes in patients with type 2 diabetes.

Managed care interface

Volumn 14, Issue 11, 2001, Pages 63-69

  Herman, M E ^a   Moore, R S ^a  

^a The Zitter Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; BLOOD; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT EDUCATION; POSTPRANDIAL STATE; TREATMENT OUTCOME; UNITED STATES;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; PATIENT COMPLIANCE; PATIENT EDUCATION; POSTPRANDIAL PERIOD; TREATMENT OUTCOME; UNITED STATES;

EID: 0035514008     PISSN: 10965645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)